|
AFS: September 11-13 | UGIRA: September 13-14
|
|
To sign up, register using the links provided below or via the Whova Mobile App. |
Thank you to all our Meal and Learn sponsors!
 |
Thursday, September 11 Join Merit Medical for dinner at AFS 2025 on Thursday, September 11 and learn from Dr. Kenneth Chang and Dr. Ninh Nguyen as they address the Critical Anatomical Components of the Anti-Reflux Barrier. Dr. Nguyen will address the TIF 2.0® Procedure and the Anti-Reflux Barrier journey while Dr. Chang will specifically address the Current and Future state of cTIF®: Clinical Evidence, Guidelines, and Best Practices. A panel of esteemed colleagues will also address any questions you may have regarding the cTIF procedure. Seats are limited. |
 |
Friday, September 12 Attend the Panel Discussion at AFS 2025 and learn: ✅ How does RefluxStop® work if it does not encircle the LES? ✅ What does European data tell us about patient selection? ✅ What new clinical data is in development to further support safety and efficacy? *Pending PMA approval, not available for sale within the United States. RefluxStop® is not available for sale in the US and Canada. Contact Implantica for availability in your region. [email protected] |
 |
Friday, September 12 Transform the Way You Manage Eosinophilic Esophagitis (EoE) in Adult Patients
|
 |
Friday, September 12 Targeted Therapy, Tailored Care: Optimizing Gastroparesis Management with Enterra Therapy A Collaborative Perspective from Gastroenterology and Surgery |
 |
Friday, September 12 The Power of a First-in-Class Acid Suppressant: A Novel Treatment Option for Adults With GERD or H. Pylori Infection Join Dustin Carlson, MD, MSCI for an engaging session on therapeutic options for the treatment of GERD (gastroesophageal reflux disease) or H. pylori infection in adults.
|
 |
Friday, September 12 Please join us for a discussion on Friday, September 12 at 12pm cst, with Dr. Gareth Weiner, MD and Gastroenterologist, as we look at answering an unmet need in pediatric and adult patients with Eosinophilic Esophagitis (EoE) through an oral therapeutic option, EOHILIA (budesonide oral suspension). EOHILIA is a ready-to-use oral suspension that was designed specifically for EoE. Please use the link below to register for this lunch and learn event. |
 |
Friday, September 12 Sharing Endoflip™ Expertise Medtronic is excited to invite members of the American Foregut Society to a unique "dinner and learn" event at this year’s annual meeting. Join Medtronic and expert Endoflip™ users specializing in foregut surgery and gastroenterology for engaging, small-group discussions. Each table will focus on a specific clinical application of Endoflip™, where an expert will share case studies, offer best practices, and lead open Q&A sessions. Register now to join these valuable discussions and secure your spot at the table that best matches your interests! |
 |
Friday, September 12 |
 |
Saturday, September 13 Risk stratification of patients with Barrett's esophagus traditionally considered at low risk of progression to HGD/EAC Risk stratification of patients with Barrett's esophagus traditionally considered at low risk of progression to HGD/EAC: Dr. Jennifer Kolb will speak on the changing risk-stratification paradigm related to non-dysplastic Barrett's esophagus, in particular, those population subsets that have been traditionally considered low risk. |
 |
Saturday, September 13 Redo Paraesophageal Hernia Repairs: Is it Recurrence or Progression? Let's Debate! Join TELA Bio at the American Foregut Society Meeting for a lively lunch and learn that's anything but boring. We're bringing together three renowned experts ready to tackle the hot topic in foregut surgery: Redo Paraesophageal Hernia Repairs - Is it Recurrence or Progression? Gain valuable insights and strategies on how to help prevent both recurrence and progression in your practice. Don't miss the conversation or the delicious lunch! |
 |
Saturday, September 13 Foregut* Surgery with da Vinci 5: Enhanced Precision and Operational Efficiency |
Industry Partners
